Rocket Pharma prices stock offering at $17.50

|About: Rocket Pharmaceuticals, Inc. (RCKT)|By:, SA News Editor

Rocket Pharmaceuticals (NASDAQ:RCKT) prices its public offering of 4.5M common shares at $17.50 per share, for expected gross proceeds of $78,750,000.

Underwriters over-allotment is an additional 675,000 shares.

Net proceeds will be used to fund the development of its pipeline of gene therapies for rare diseases, to accelerate the buildout of in-house manufacturing capabilities, and for general corporate purposes.

Closing date is April 18.

Previously: Rocket Pharma down 5% after hours on equity offering (April 15)

Subscribe for full text news in your inbox